Last reviewed · How we verify

NCT03052361

Triage Administration of Ondansetron for Gastroenteritis in Children

Terminated Phase 2, PHASE3 Last updated 22 October 2020
What this trial tests

Phase 2, PHASE3 trial testing Ondansetron in Gastroenteritis in 81 participants. Terminated before completion.

Timeline
15 July 2017
Primary endpoint
3 September 2020
3 October 2020

Quick facts

Lead sponsorSt. Justine's Hospital
PhasePhase 2, PHASE3
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment81
Start date15 July 2017
Primary completion3 September 2020
Estimated completion3 October 2020
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

St. Justine's Hospital

Who can join

Adults 6 Months to 17, any sex, with Gastroenteritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to assess whether ondansetron given at triage can reduce the number of patients requiring emergency department observation in children with acute gastroenteritis. The investigators will also assess the improvement of patient comfort and total length of stay

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ondansetron

Trials testing the same drug.

Other recruiting trials for Gastroenteritis

Currently open trials in the same condition.

Other St. Justine's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03052361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing